Altre lingue Skinvisible, Inc.

Azioni

SKVI

US8307032032

Mercato chiuso - OTC Markets Altri mercati azionari 19:16:43 11/07/2024			Variaz. 5gg	Var. 1 gen.
0,69 ^USD	+35,29%		+9,52%	+723,39%

09/07	Skinvisible Pharmaceuticals, Inc. presenta dati promettenti sulle formulazioni transdermiche per l'obesità	CI
15/05	Skinvisible, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Skinvisible Pharmaceuticals, Inc. Unveils Promising Data on Transdermal Obesity Formulations	09/07
Skinvisible, Inc. announced that it has received $0.035 million in funding	04/06
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome	15/02
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/03/23
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)	14/11/22
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)	10/08/22
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/08/22
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)	16/05/22
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	31/03/22
Skinvisible, Inc. Auditor Raises 'Going Concern' Doubt	31/03/22
SKINVISIBLE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	13/01/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Skinvisible, Inc.

Azioni

SKVI

US8307032032

Altre lingue

Filtri